|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
19 February 2015 |
|
Main ID: |
NCT00189787 |
|
Date of registration:
|
12/09/2005 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Dose Response of Inhaled Tacrolimus in Patients With Moderate Persistent Asthma
|
|
Scientific title:
|
|
|
Date of first enrolment:
|
August 2004 |
|
Target sample size:
|
370 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00189787 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment
|
|
Phase:
|
Phase 2
|
|
|
Countries of recruitment
|
|
Bulgaria
|
Czech Republic
|
Germany
|
Hungary
|
Poland
|
Russian Federation
|
Ukraine
| |
|
Contacts
|
|
Name:
|
R.G.M.vom Amsterdam, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Astellas Pharma Europe B.V. |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Diagnosis of asthma
- Patients treated with inhaled corticosteroid
- FEV1 (forced expiratory volume in 1 second)>60% to 80%
Exclusion Criteria:
- Respiratory infection within 2 weeks
- Asthma exacerbation within 90 days
Age minimum:
18 Years
Age maximum:
70 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Asthma, Bronchial
|
|
Bronchial Asthma
|
|
Intervention(s)
|
|
Drug: tacrolimus
|
|
Secondary ID(s)
|
|
FG-506-17-07
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|